We are live on ! Find out more
JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

132 hedge funds and large institutions have $2.17B invested in Juno Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

14% less funds holding

Funds holding: 154 → 132 (-22)

14% less capital invested

Capital invested by funds: $2.54B → $2.17B (-$365M)

34% less call options, than puts

Call options by funds: $29.5M | Put options by funds: $44.9M

38% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 56

Holders
132
Holders Change
-22
Holders Change %
-14.29%
% of All Funds
3.68%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
35
Increased
54
Reduced
28
Closed
56
Calls
$29.5M
Puts
$44.9M
Net Calls
-$15.4M
Net Calls Change
+$15.4M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$131M
2
BB
BB Biotech
Switzerland
+$37.5M
3
BIT
BlackRock Institutional Trust
California
+$29M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.7M
5
State Street
State Street
Massachusetts
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$15.6M
3
RCM
RA Capital Management
Massachusetts
-$14.9M
4
JP Morgan Chase
JP Morgan Chase
New York
-$13.2M
5
DM
Deerfield Management
New York
-$9.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Parallax Volatility Advisers
151
Parallax Volatility Advisers
California
– -$535K -12,200 Closed
Simplex Trading
152
Simplex Trading
Illinois
– -$509K -11,597 Closed
JC
153
Jetstream Capital
Tennessee
– -$613K -11,500 Closed
SM
154
Sabby Management
Florida
– -$604K -11,333 Closed
ST
155
Spot Trading
Illinois
– -$452K -10,313 Closed
PIM
156
Partner Investment Management
California
– -$544K -10,194 Closed
EMG
157
Ellington Management Group
Connecticut
– -$528K -9,897 Closed
ZIM
158
Zacks Investment Management
Illinois
– -$487K -9,134 Closed
JMPWA
159
JP Morgan Private Wealth Advisors
California
– -$466K -8,750 Closed
NCCM
160
Nine Chapters Capital Management
New Jersey
– -$400K -7,500 Closed
AQR Capital Management
161
AQR Capital Management
Connecticut
– -$384K -7,200 Closed
HCM
162
Highbridge Capital Management
New York
– -$382K -7,150 Closed
CSS
163
Cubist Systematic Strategies
Connecticut
– -$379K -7,107 Closed
Tudor Investment Corp
164
Tudor Investment Corp
Connecticut
– -$335K -6,282 Closed
SG Americas Securities
165
SG Americas Securities
New York
– -$331K -6,214 Closed
SCM
166
Stevens Capital Management
Pennsylvania
– -$308K -5,773 Closed
LPL Financial
167
LPL Financial
California
– -$302K -5,550 Closed
NI
168
Numeric Investors
Massachusetts
– -$267K -5,000 Closed
OPPM
169
Opus Point Partners Management
New York
– -$267K -5,000 Closed
WSA
170
Wall Street Associates
California
– -$267K -5,000 Closed
ICAS
171
Investors Capital Advisory Services
Massachusetts
– -$239K -4,500 Closed
PC
172
Passport Capital
California
– -$232K -4,356 Closed
EGM
173
Engineers Gate Manager
New York
– -$230K -4,312 Closed
PPA
174
Parametric Portfolio Associates
Washington
– -$224K -4,209 Closed
BJL
175
Brighton Jones LLC
Washington
– -$220K -4,130 Closed
4 5 6
7
8

JUNO Hedge Fund Activity: Q3 2015 in Review

132 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Juno Therapeutics, Inc. (JUNO) for Q3 2015, worth a combined $2.17B — down 14% from $2.54B a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of JUNO and 35 opened new positions — a net loss of 21 holders — while 28 trimmed existing stakes and 54 added.

The largest buyer was Vanguard Group, adding an estimated $131M. The largest seller was Lord, Abbett & Co, cutting an estimated $16.3M.

  • 132 institutional investors held Juno Therapeutics, Inc. (JUNO) as of Q3 2015, down from 154 in Q2 2015.
  • Funds reported $2.17B of Juno Therapeutics, Inc. stock for Q3 2015, down 14% quarter-over-quarter.
  • 35 funds opened new Juno Therapeutics, Inc. positions in Q3 2015 and 56 closed out, a net change of -21 holders.
  • The largest Juno Therapeutics, Inc. buyer in Q3 2015 was Vanguard Group, an estimated $131M added.
  • The largest Juno Therapeutics, Inc. seller in Q3 2015 was Lord, Abbett & Co, an estimated $16.3M sold.

Based on aggregated 13F filings for Q3 2015.